Evaluation of the Clinical Relevance of Body Composition Parameters in Patients With Cancer Metastatic to the Liver Treated With Hepatic Arterial Infusion Chemotherapy

REFERENCES

• Bianchini , F , Kaaks , R and Vainio , H . 2002 . Overweight, obesity, and cancer risk . Lancet Oncol , 3 : 565 – 574 .
   PubMed Web of Science ®Google Scholar
• Renehan , A G , Tyson , M , Egger , M , Heller , R F and Zwahlen , M . 2008 . Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies . Lancet , 371 : 569 – 578 .
   PubMed Web of Science ®Google Scholar
• Murthy , N S , Mukherjee , S , Ray , G and Ray , A . 2009 . Dietary factors and cancer chemoprevention: an overview of obesity-related malignancies . J Postgrad Med , 55 : 45 – 54 .
   PubMed Web of Science ®Google Scholar
• Sarhill , N , Mahmoud , F , Walsh , D , Nelson , K A Komurcu , S . 2003 . Evaluation of nutritional status in advanced metastatic cancer . Support Care Cancer , 11 : 652 – 659 .
   PubMed Web of Science ®Google Scholar
• Evans , W J , Morley , J E , Argiles , J , Bales , C Baracos , V . 2008 . Cachexia: a new definition . Clin Nutr , 27 : 793 – 799 .
   PubMed Web of Science ®Google Scholar
• Ma , G and Alexander , H R . 1998 . “ Prevalence and pathophysiology of cancer cachexia ” . In Topics in Palliative Care , 91 – 129 . New York : Oxford University Press .
   Google Scholar
• Deans , D A , Wigmore , S J , de Beaux , A C , Paterson-Brown , S Garden , O J . 2007 . Clinical prognostic scoring system to aid decision-making in gastro-oesophageal cancer . Br J Surg , 94 : 1501 – 1508 .
   PubMed Web of Science ®Google Scholar
• Fearon , K C , Voss , A C and Hustead , D S . 2006 . Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis . Am J Clin Nutr , 83 : 1345 – 1350 .
   PubMed Web of Science ®Google Scholar
• Dewys , W D , Begg , C , Lavin , P T , Band , P R Bennett , J M . 1980 . Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group . Am J Med , 69 : 491 – 497 .
   PubMed Web of Science ®Google Scholar
• Fouladiun , M , Korner , U , Gunnebo , L , Sixt-Ammilon , P Bosaeus , I . 2007 . Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia . Clin Cancer Res , 13 : 6379 – 6385 .
   PubMed Web of Science ®Google Scholar
• Hinsley , R and Hughes , R . 2007 . “The reflections you get”: an exploration of body image and cachexia . Int J Palliat Nurs , 13 : 84 – 89 .
   PubMedGoogle Scholar
• Dahele , M , Skipworth , R J , Wall , L , Voss , A Preston , T . 2007 . Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy . J Pain Symptom Manage , 33 : 676 – 685 .
   PubMed Web of Science ®Google Scholar
• Morley , J E , Baumgartner , R N , Roubenoff , R , Mayer , J and Nair , K S . 2001 . Sarcopenia . J Lab Clin Med , 137 : 231 – 243 .
   PubMed Web of Science ®Google Scholar
• Roubenoff , R . 2008 . Excess baggage: sarcopenia, obesity, and cancer outcomes . Lancet Oncol , 9 : 605 – 607 .
   PubMed Web of Science ®Google Scholar
• Roubenoff , R . 2003 . Sarcopenia: effects on body composition and function . J Gerontol A Biol Sci Med Sci , 58 : 1012 – 1017 .
   PubMed Web of Science ®Google Scholar
• Roubenoff , R . 2002 . Exercise, sarcopenia, cognition, and mood . Nestle Nutr Workshop Ser Clin Perform Programme , 6 : 151 – 159 . 160 – 162 . discussion
   PubMedGoogle Scholar
• Prado , C M , Lieffers , J R , McCargar , L J , Reiman , T Sawyer , M B . 2008 . Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study . Lancet Oncol , 9 : 629 – 635 .
   PubMed Web of Science ®Google Scholar
• Prado , C M , Baracos , V E , McCargar , L J , Reiman , T Mourtzakis , M . 2009 . Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment . Clin Cancer Res , 15 : 2920 – 2926 .
   PubMed Web of Science ®Google Scholar
• Antoun , S , Baracos , V E , Birdsell , L , Escudier , B and Sawyer , M B . 2010 . Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma . Ann Oncol , 21 : 1594 – 1598 .
   PubMed Web of Science ®Google Scholar
• Barber , F D , Mavligit , G and Kurzrock , R . 2004 . Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview . Cancer Treat Rev , 30 : 425 – 436 .
   PubMed Web of Science ®Google Scholar
• Kemeny , N , Huang , Y , Cohen , A M , Shi , W Conti , J A . 1999 . Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer . N Engl J Med , 341 : 2039 – 2048 .
   PubMed Web of Science ®Google Scholar
• Tsimberidou , A M , Fu , S , Ng , C , Lim , J A Wen , S . 2010 . A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver . Cancer , 116 : 4086 – 4094 .
   PubMed Web of Science ®Google Scholar
• Hohn , D C , Stagg , R J , Friedman , M A , Hannigan , J F Jr. Rayner , A . 1989 . A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial . J Clin Oncol , 7 : 1646 – 1654 .
   PubMed Web of Science ®Google Scholar
• Lorenz , M and Muller , H H . 2000 . Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma . J Clin Oncol , 18 : 243 – 254 .
   PubMed Web of Science ®Google Scholar
• Kerr , D J , McArdle , C S , Ledermann , J , Taylor , I Sherlock , D J . 2003 . Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial . Lancet , 361 : 368 – 373 .
   PubMed Web of Science ®Google Scholar
• Ducreux , M , Ychou , M , Laplanche , A , Gamelin , E Lasser , P . 2005 . Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer . J Clin Oncol , 23 : 4881 – 4887 .
   PubMed Web of Science ®Google Scholar
• Cancer Therapy Evaluation Program . National Cancer Institute Common Toxicity Criteria version 3.0
   Google Scholar
• Billewicz , W Z , Kemsley , W F and Thomson , A M . 1962 . Indices of adiposity . Br J Prev Soc Med , 16 : 183 – 188 .
   PubMedGoogle Scholar
• Mourtzakis , M , Prado , C M , Lieffers , J R , Reiman , T McCargar , L J . 2008 . A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care . Appl Physiol Nutr Metab , 33 : 997 – 1006 .
   PubMed Web of Science ®Google Scholar
• Shen , W , Punyanitya , M , Wang , Z , Gallagher , D St-Onge , M P . 2004 . Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image . J Appl Physiol , 97 : 2333 – 2338 .
   PubMed Web of Science ®Google Scholar
• Shen , W , Punyanitya , M , Wang , Z , Gallagher , D St-Onge , M P . 2004 . Visceral adipose tissue: relations between single-slice areas and total volume . Am J Clin Nutr , 80 : 271 – 278 .
   PubMed Web of Science ®Google Scholar
• Mitsiopoulos , N , Baumgartner , R N , Heymsfield , S B , Lyons , W Gallagher , D . 1998 . Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography . J Appl Physiol , 85 : 115 – 122 .
   PubMed Web of Science ®Google Scholar
• Heymsfield , S B , Smith , R , Aulet , M , Bensen , B Lichtman , S . 1990 . Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry . Am J Clin Nutr , 52 : 214 – 218 .
   PubMed Web of Science ®Google Scholar
• Miller , K D , Jones , E , Yanovski , J A , Shankar , R Feuerstein , I . 1998 . Visceral abdominal-fat accumulation associated with use of indinavir . Lancet , 351 : 871 – 875 .
   PubMed Web of Science ®Google Scholar
• Therasse , P , Arbuck , S G , Eisenhauer , E A , Wanders , J Kaplan , R S . 2000 . New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada . J Natl Cancer Inst , 92 : 205 – 216 .
   PubMed Web of Science ®Google Scholar
• Ratain , M J , Eisen , T , Stadler , W M , Flaherty , K T Kaye , S B . 2006 . Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma . J Clin Oncol , 24 : 2505 – 2512 .
   PubMed Web of Science ®Google Scholar
• Tan , B H , Birdsell , L A , Martin , L , Baracos , V E and Fearon , K C . 2009 . Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer . Clin Cancer Res , 15 : 6973 – 6979 .
   PubMed Web of Science ®Google Scholar
• Parsons , H A , Baracos , V , Dhillon , N and Kurzrock , R . 2010 . A preliminary investigation of body composition, symptom burden and survival in a phase i clinical trials service . Support Care Cancer , 18 : S140 (abstract)
   Google Scholar
• Thompson Reuters . Micromedex v. 1.0. 2010
   Google Scholar
• Dzodic , R , Gomez-Abuin , G , Rougier , P , Bonnay , M Ardouin , P . 2004 . Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model . Anticancer Drugs , 15 : 647 – 650 .
   PubMed Web of Science ®Google Scholar
• Prado , C M , Baracos , V E , McCargar , L J , Mourtzakis , M Mulder , K E . 2007 . Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity . Clin Cancer Res , 13 : 3264 – 3268 .
   PubMed Web of Science ®Google Scholar